By Sam Cage and Sven Egenter ZURICH (Reuters) - GlaxoSmithKline Ltd GSK could pay Swiss company Actelion Ltd ATLN up to 3.3 billion Swiss francs ($3.28 billion) to develop a promising insomnia drug in the largest biotech partnering deal. Glaxo, Europe's biggest drugmaker,...
By Ben Hirschler LONDON (Reuters UK) - The world's two biggest drugmakers, Pfizer PFE and GlaxoSmithKline GSK, both beat expectations for quarterly earnings on Wednesday, as did Wyeth WYE, indicating the sector's resilience. Although all three companies face major threats from generic competition, the latest...
By Ben Hirschler LONDON (Reuters) - The world's two biggest drugmakers, Pfizer Inc PFE and GlaxoSmithKline Plc GSK, both beat expectations for quarterly earnings on Wednesday, as did Wyeth WYE, indicating the sector's resilience. Although all three companies face major threats from ...
By Sam Cage and Sven Egenter ZURICH (Reuters UK) - GlaxoSmithKline GSK could pay Swiss company Actelion ATLN up to 3.3 billion Swiss francs (1.6 billion pounds) to develop a promising insomnia drug in the largest biotech partnering deal. Glaxo, Europe's biggest drugmaker, beat many of...
By Lewis Krauskopf NEW YORK (Reuters) - Teva Pharmaceutical Industries, the world's largest generic drug company, said on Friday it would buy rival Barr Pharmaceuticals Inc for $7.46 billion to expand its leadership in the U.S. market and fortify its presence in Europe....
By Sophie Taylor SHANGHAI (Reuters UK) - GlaxoSmithKline GSK, the world's second-largest drugmaker, plans to double its research and development staff in China to 350 people in the next few years, an executive said on Tuesday. The company currently employs 170 R&D staff in China and...
As the move to increasingly selective - and potent - formulations continues, drug manufacturers are looking for new ways to protect operators from exposure to extremely potent ingredients while maintaining production efficiency. Traditionally, workers have been shielded by personnel protective equipment PPE, such as uncomfortable "space suits" that take time...
A Pfizer public education campaign and its cute mascot are praiseworthy, but neglect to mention the key stage in a drug's life. What will it take to make manufacturing a hot button issue and to better educate the public? Given the current consumer and media backlash against drug makers, there's...
Chances are good that if you're a drug-industry scientist, you already know Derek Lowe's blog In the Pipeline, which often as not focuses on the complexities of chemical synthesis and research management. Even though he works at a lab bench, Lowe also has an excellent sense of what makes pharmaceutical...
Japanese drugmakers are anxious to expand their presence in global pharma/biotech markets where they've long been largely shut out -- and the strong yen is making it cheaper for them to basically buy their way in. Interestingly enough, some of these deals are bypassing the U.S. altogether. ...
Well before Vytorin became a cause célèbre -- which is to say, about a year ago -- GlaxoSmithKline's Avandia was the drug getting slapped around by critics for, in that case, possible heart problems that had possibly been downplayed or ignored. That case, which led to new warnings on the...
Big Pharma continues to lend new meaning to the phrase "doing more with less," because while the industry seems to get smaller every day, drugmakers are still pushing through big price increases on their leading products. Over at Pharmalot, Ed Silverman provides a helpful roundup tracking the...
Although some pharmaceutical company efforts to develop and distribute drugs in developing countries have been successful, many fall short of meeting needs in resource-poor nations. The paper discusses the concept of a nonprofit pharmaceutical company dedicated to developing and distributing drugs for diseases endemic in developing countries. Using the experience...
To evaluate the impact of their responses, this report compares the draft, the changes requested by industry and organized medicine, and the final Guidance document. This draft Guidance questioned the legality of many arrangements heretofore left to the discretion of physicians and drug companies, including industry-funded educational and research grants,...
There has been much movement by drug companies in altering wholesaler buying patterns through various inventory agreements, with a noticeable majority already having some agreement in place. There has been real movement by drug manufacturers to change the profit models of their wholesalers through a de-emphasis on channel incentives. The...
In direct to consumer advertising, drug companies target advertisements for prescription drugs directly at the public. This paper argues that this type of advertising risks medical sing normal human conditions, with the drug companies raking in increasingly healthy profits. The paper argues that, through advertising, drug companies can enable patients...
As pharmaceuticals struggle to get doctors to take their medicine, they ignore the valuable branding resources available on the web. Most pharmaceutical branding rarely goes beyond the trademarked name, at least for patients. But among the professional medical community, drug companies embrace the scope for building a more complete brand...
[ILLUSTRATION OMITTED] Royal Marines from 40 Commando have destroyed a drugs factory in the Upper Sangin Valley along with 1.5 tonnes of morphine base--the precursor of heroin. The Commandos from Bravo Company discovered compounds in Sapwan Kala, Afghanistan also uncovered evidence--some in English--of bank accounts, along...
Amazon Biotech, Inc. (PINKSHEETS: AMZO)(FRANKFURT: B2DA) announced that the 14A shareholder meeting set for July17, 2008, to elect a three member Board of Directors and to address suchother matters that may properly come before the meeting has beenpostponed in order to allow time to file a preliminary 14A...
Conformia, the market leader of product andprocess lifecycle management PPLM solutions for life sciences, todayintroduced the Conformia Design Suite, a Web-based software solution thatautomates the design of new drugs during the lab scale environment. TheDesign Suite completes Conformia's Product and Process lifecycle managementoffering for Pharma by providing full capabilities from...
